Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf, John W. Eikelboom, Jonas Oldgren, Amit Parekh, Janice Pogue, Paul Reilly, Ellison Themeles, Jeanne Varrone, Susan Wang, Marco Alings, Denis Xavier, Jun Zhu, Rafael Díaz, Basil S. Lewis, Harald Darius, Hans‐Christoph Diener, Campbell Joyner, Lars Wallentin

New England Journal of Medicine, 2009

McMaster University, Population Health Research Institute, Hamilton Health Sciences, Lankenau Institute for Medical Research, Boehringer Ingelheim (United States), Utrecht University, St. John's National Academy of Health Sciences, Fu Wai Hospital, Estudios Clínicos Latinoamérica, Carmel Medical Center, Vivantes Klinikum, University of Duisburg-Essen, Sunnybrook Health Science Centre, Health Sciences Centre

View Free PDF Publisher Website

Abstract

This research paper explore the methodology and findings associated with New England Journal of Medicine. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

11144

Citations

View on Google Scholar

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Abstract

Journal Details

Join JournalsHub

Welcome Back